• Journal of the Korean Academy of Child and Adolescent Psychiatry
• /
• 제28권2호
• /
• pp.84-95
• /
• 2017

Attention-deficit hyperactivity disorder (ADHD) is a neuropsychiatric disorder that begins in early childhood and can persist throughout adulthood. ADHD causes difficulties in various area of life, such as academic achievement, peer relationships, family functioning, employment and marriage. Although ADHD is known to respond well to medication, such treatment is more effective when combined with psychosocial (non-pharmacologic) therapy in terms of alleviating the core symptoms and improving appropriate functions. Psychosocial treatment interventions are divided into psychoeducation, behavioral parent training, school intervention, cognitive behavior therapy, social skill training, parent-child interaction therapy, play therapy, other treatments (coaching, complementary and alternative medicine), neurofeedback and Cogmed. Adult ADHD cognitive behavioral therapy is described separately. These practice parameters summarize the evidence for psychosocial treatment. Based on this evidence, specific recommendations are provided for psychosocial interventions.

• 생물정신의학
• /
• 제2권2호
• /
• pp.186-192
• /
• 1995

The Neuropsychiatric assessment and management of postconcussion syndrome(PCS), the most prevalent and controversial neuropsychiatric sequelae of traumatic brain injury, were reviewed. First, the definition and general concept of postconcussion syndrome Were summerized. This summary was followed by an overview of the clinical manifestation including cognitive, somatic, and behavioral components of PCS. Next, neuropsychological findings related to PCS were presented. Finally, the treatment issues including psychotherapy and pharamacotherapy were briefly summerized.

• 대한수의학회지
• /
• 제62권3호
• /
• pp.25.1-25.9
• /
• 2022

Canine cognitive dysfunction syndrome (CDS) is a neurodegenerative disease that causes cognitive and behavioral disorders and reduces the quality of life in dogs and their guardians. This study reviewed the complementary and alternative medicine (CAM) for CDS and compared the diagnosis and therapy of CAM between CDS in canines and dementia in humans. The evaluation tools for the diagnosis of CDS and dementia were similar in the neurological and neuropsychiatric examinations, daily life activity, cognitive tests, and neuroimaging, but the evaluation for dementia was further subdivided. In CAM, pattern identification is a diagnostic method for accurate, personalized treatment, such as herbal medicine. For herbal medicine treatment of cognitive impairment in canines and humans, a similar pattern identification classified as deficiency (Qi, blood, and Yin) and Excess (phlegm, Qi stagnation, and blood stasis) is being used. However, the veterinary clinical basis for verifying the efficacy and safety of CAM therapies for CDS is limited. Therefore, based on CAM evidence in dementia, it is necessary to establish CDS-targeted CAM diagnostic methods and therapeutic techniques considering the anatomical, physiological, and pathological characteristics of dogs.

• 한국산학기술학회논문지
• /
• 제17권9호
• /
• pp.407-421
• /
• 2016

본 연구는 만성 일차성 불면증 환자에게 적용한 인지행동중재의 효과를 평가하는 16개의 논문을 메타분석한 것이다. PubMed, Cochrane Library, EMBASE, CINAHL와 여러 개의 국내 데이타 베이스를 통해 2015년 1월부터 2015년 6월까지 자료검색이 이루어졌다. 주요 검색전략은 인지행동중재와 불면증을 병합하여 이루어졌다. 논문의 방법론적 질 평가는 코크란의 RoB(The Cochrane's Risk of Bias)를 사용하였다. 자료는 Cochrane Library의 RevMan 5.3 프로그램으로 분석하였다. 최종 16편의 논문, 1503명의 대상자가 선정기준에 부합되었다. 자극조절요법, 수면제한법, 수면위생교육과 인지적 재구성이 인지행동중재의 주요 치료적 구성요소였다. 인지행동 중재의 적용 주수는 평균 5.4주, 적용횟수 평균 5.5회, 1회 평균 중재시간 90분으로 조사되었다. 인지행동중재의 효과는 총 수면시간(d=-0.31), 수면 잠복기(d=-0.29), 입면 후 각성시간(d=-0.55), 수면효율성(d=-0.70), 불면증 심각성(d=-0.77)과 수면에 대한 신념 및 태도(d=-0.64)에 유의하였다. 전반적으로 작은 효과크기에서 중간 정도의 효과크기를 나타냈다. 인지행동중재는 불안(d=-0.30)과 우울(d=-0.35)에도 효과적이었다. 이러한 결과는 인지행동중재가 불면증이 있는 환자들의 수면의 질과 수면시간을 증진시키는 것으로 나타났다.

• Journal of the Korean Academy of Child and Adolescent Psychiatry
• /
• 제29권2호
• /
• pp.73-79
• /
• 2018

Objectives: The overuse of the Internet among adolescents has increased dramatically in recent years, leading to pathological or problematic Internet use. Cognitive behavioral therapy (CBT) is known to be effective for the treatment of problematic Internet use, particularly for adolescents. The aim of the present study was to evaluate the therapeutic efficacy of group CBT for problematic Internet use in adolescents. Methods: A total of 17 patients aged 12-17 years who met Young's diagnostic questionnaire criteria of problematic Internet use participated in a school-based eight-session group CBT program. The level of problematic Internet use among participating students was measured using Young's Internet Addiction Scale (IAS). Depression and anxiety levels were evaluated using the Children's Depression Inventory (CDI) and the State-Trait Anxiety Inventory (STAI), respectively. Each construct was assessed at baseline, immediately after the intervention, and at a one-month follow-up visit. Statistical significance was based on a p-value of <0.05. Results: Immediately after the program, the IAS, CDI, and State Anxiety Inventory (SAI) scores were significantly lower than before the program. At the one-month follow-up assessment, the IAS scores remained low, and the CDI and SAI scores were even lower than immediately after the program. Conclusion: Group CBT was effective for adolescents with problematic Internet use, and was also demonstrated to improve depression and anxiety.

• 정신신체의학
• /
• 제11권2호
• /
• pp.205-213
• /
• 2003

목 적: 본 연구에서는 집단인지행동치료의 장기적 치료효과를 평가해 보고자 하였으며, 12개월 추적 연구에서 환자들의 상위 최종상태기능을 예측해 볼 수 있는 치료적 변인을 확인하고자 하였다. 방 법: 공황장애로 진단받고 집단인지행동치료를 받은 329명의 환자들을 대상으로 12개월 추적 연구를 하였으며, 최종적으로 분석에 포함된 환자들은 236명이었다. 12개월 추적 연구에서 환자들의 최종상태기능을 확인하였으며, 상위 최종상태기능 집단(HES)과 하위 최종상태기능 집단(LES)을 판별해주는 변인을 알아보기 위해서, 치료 전의 임상적 변인을 대상으로 단계적 판별분석을 실시하였다. 결 과: 집단 인지행동치료를 실시한 후, 12개월 추적 연구 시 75%의 환자들이 상위 최종상태기능을 유지하고 있는 것으로 나타났다. 12개월 추적 연구 시 상위 최종상태기능 집단과 하위 최종상태기능 집단을 판별해 주는 변수로 치료 전에 실시한 BDI(Beck Depression Inventory)와 BSQ(Body Sensation Questionnaire)가 유의미한 것으로 나타났으며, 정확 판별율은 69.2%였다. 결 론: 본 연구를 통하여 공황장애의 집단인지행동치료 이후에 12개월 이상 장기적으로 치료적 효과가 유지됨을 알 수 있었다. 특히 치료 전, 후 변인을 대상으로 판별 분석을 실시한 결과, 우울감이 적고 신체적 증상을 덜 예민하게 경험하는 사람들일수록 인지행동치료의 효과가 장기적으로 잘 유지된다는 사실을 확인할 수 있었다.

• Journal of the Korean Academy of Child and Adolescent Psychiatry
• /
• 제23권2호
• /
• pp.49-56
• /
• 2012

Methylphenidate is a widely used stimulant for treatment of attention-deficit hyperactivity disorder (ADHD). In addition to core symptoms of attention and behavioral symptoms, methylphenidate is even effective for executive functions. However, abuse and misuse of stimulants, including methylphenidate, for the purpose of cognitive enhancement is an issue of concern worldwide. Some prejudices and misunderstandings against methylphenidate are popular ; however, little attention has been given to the neuropsychiatric evidence of methylphenidate for enhancement of cognitive function among healthy populations. In this article, our aim was to conduct a review of previous studies investigating the effect of methylphenidate in healthy populations. Findings from several recent studies have demonstrated the effectiveness of methylphenidate for enhancement of cognitive function in healthy populations. The mechanisms of cognitive enhancement are thought to be associated with motivation and the reward circuit in the brain. However, when considering the risk to benefit, an official discussion of the use of methylphenidate among healthy members of the population would be premature. Instead, investigation of epidemiological studies of the prevalence of misuse of stimulants among healthy members of the population, particularly adolescents and college students, is needed. In addition, based on achievements reported in previous studies, investigation of the effect of an approach using non-pharmacological enhancing motivation, which will in turn result in increased cognitive function would be helpful.

• 동의생리병리학회지
• /
• 제23권5호
• /
• pp.1080-1086
• /
• 2009

This study was designed to investigate the effects of Gastrodiae Elata Pharmacopuncure at GB20 on motor control and cognitive dysfunction recovery after mild traumatic brain injury in rats. Rats were divided into three groups; (1) no treatment after traumatic brain injury(experiment I), (2) Treatment with NPA after traumatic brain injury(experiment II), (3) Treatment with GEP after traumatic brain injury(experiment III). In our study, we carried out behavioral test(Rotarod, Morris water maze) and immunohistochemistry study of the change BDNF in the hippocampus(pre, $7^{th}$, $14^{th}$ day). In Rotarod test(motor control function) was significantly increased in the experimental group III as compared with experimental group I, II on $7^{th}$(p<0.01) and $14^{th}$ day(p<0.001). In Morris water maze test(cognitive function) was significantly decreased in the experimental group III as compared with experimental group I, II on $14^{th}$ day(p<0.001). In immunohistochemistric response of BDNF in the hippocampus, the experimental group III was more immune response than the other groups on $14^{th}$ day. These results imply that Gastrodiae Elata Pharmacopuncure at GB20 can play a role in facilitating recovery of motor control and cognitive function after mild traumatic brain injury in rats.

• 정신신체의학
• /
• 제31권1호
• /
• pp.1-9
• /
• 2023

신경인지장애 환자들은 인지저하 뿐만 아니라 초조, 공격성, 우울, 배회 등의 정신행동증상들을 나타내며 이로 인해 환자와 가족이 상당한 고통을 받게 된다. 정신행동증상의 치료를 위해서는 환자 중심의, 비약물학적인 치료가 우선되어야한다. 본 논문은 신경인지장애 환자에서 나타나는 정신행동증상을 관리하고 치료하기 위한 비약물학적인 개입에 대하여 기술하였다. 초조, 우울, 무감동, 불면, 배회 등의 정신행동증상을 조절하기 위해서는 환경변화, 약물 등의 유발 인자를 파악하고 평가한 뒤, 그러한 문제를 해결해주는 것이 중요하다. 비약물학적인 개입 방법으로는 안심시키기, 활동 격려하기, 주의를 분산시키기, 환경을 변화시키기 등을 들 수 있다. 환자의 관점에서 행동을 이해하고, 그들의 요구와 능력에 맞게 접근해야한다. 비약물학적인 개입 방법으로 회상요법, 음악치료, 향기요법, 다중감각자극요법, 운동요법, 광선치료, 마사지 요법, 인지중재치료, 애완동물요법 등의 다양한 요법이 시행되고 있으며, 이러한 접근 방법이 환자의 우울, 무감동, 초조, 공격성, 불안, 배회, 불면 등의 증상을 호전시켜준다고 알려져 있다. 그러나, 효과에 대한 증거 수준이 높지 않아 향후에 좀 더 광범위하고 정확한 효과 검증 연구가 필요하다.

• 수면정신생리
• /
• 제8권1호
• /
• pp.5-10
• /
• 2001

The prevalence of insomnia and the degree of impairment due to insomnia is greater than in the of young. The cause for insomnia in the elderly are various factors among the elderly is known to be high including medical, psychiatric, drug issues, circadian rhythm changes, sleep disorders, and psychosocial. So the careful evaluation to find the cause of insomnia is needed for the eldery. Treatment options for insomnia include behavior modification and pharmacotherapy. Outcome data from previous studies indicate that behavioral approaches produce reliable and durable therapeutic benefits, as evidenced by improved sleep efficiency and continuity and enhanced satisfaction with sleep patterns. Treatment methods such as stimulus control and sleep restriction, which target maladaptive sleep habits, are especially beneficial for older insomniacs, whereas relaxation-based interventions aimed at decreasing arousal, produce more limited effects. Cognitive and educational interventions are instrumental in altering age-related dysfunctional beliefs and attitudes about sleep. The choice of hypnotics is based on matching the nature of the insomnia to the hypnotic agent. The ideal agent has rapid onset, duration of action that lasts through the night but no residual daytime effects, and no adverse effects. The key for the healthcare professional is finding the appropriate treatment or treatment combination, including behavioral modification and pharmacotherapy. When hypnotics are indicated, the most appropriate short-acting agent should be considered.